Ainos (AIMD)
Builds AI olfaction hardware and scent-data software alongside oral-interferon development.
Something off on this page? Send us feedback.
Builds AI Nose hardware that converts odor patterns into Smell IDs and pairs it with AI-based interpretation for industrial and healthcare applications, while also advancing the VELDONA oral-interferon program. Product sales and technical or development work are disclosed revenue sources within one reportable segment.
Combines AI Nose / SmellTech with VELDONA, a very-low-dose oral interferon-alpha development program. Its sensing hardware captures volatile-organic-compound patterns as Smell IDs; the AI smell-language model and ScentAI are intended to interpret those data for robotics, smart factories, semiconductor environments, and healthcare. Product sales and technical or development work are the disclosed revenue mechanisms, while the current materials do not establish a mature recurring software or data-licensing mix.
Operates as a Houston-listed parent with substantial Taiwan-linked sensing and biotechnology development activity. Commercial scaling depends on repeatable sensor performance, customer integration, useful odor-data generation, and ScentAI's delivery of intelligence; healthcare uses require application-specific evidence and regulatory authorization. VELDONA remains a development program.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $1.4M · Total debt $13.8M · Total assets $19.6M · Shareholders' equity $3.3M
- Revenue
- $152
- Operating income
- −$4.4M
- Net income
- −$4.6M
No dividends on record.
| Institutions12 holders · as of Mar 31, 2026 | 1.80% | 132.9K shares | |
| Insiders8 holders · as of Jun 9, 2026 | 35.71% | 2.64M shares | |
| Strategic holders3 holders · as of May 27, 2026 | 28.72% | 2.12M shares | |
| Otherremainder | 33.77% | 2.49M shares |
7.38M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
ScentAI Inc.Strategic | 15.71% | 1.16M | 13Dfiled Jan 27, 2026 ↗ |
Taiwan Carbon Nano Technology CorpStrategic10 percent owner | 12.85% | 948,925 | Form 4filed May 27, 2026 ↗ |
ting-chuan leeInsiderdirector | 10.93% | 807,417 | Form 4filed May 27, 2026 ↗ |
chun-hsien tsaiInsiderdirector, officer: CEO, PRESIDENT, CHAIRMAN | 9.62% | 710,372 | Form 4filed Apr 17, 2026 ↗ |
Chun-Jung TsaiInsiderdirector | 8.91% | 658,199 | Form 4filed May 27, 2026 ↗ |
| See all 25 → | |||
13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 5, 2026 | yao-chung chiang | director | +3,500 | $2.05 |
| Jun 3, 2026 | yao-chung chiang | director | +2,000 | $2.13 |
| May 28, 2026 | yao-chung chiang | director | +250 | $2.30 |
| May 27, 2026 | yao-chung chiang | director | +2,000 | $2.00 |
| May 26, 2026 | Chun-Jung Tsai | director | −27,718 | $1.87 |
- Senseonics
VOC and environmental sensor supplier for connected air monitoring.
- Honeywell Technologies
Scaled industrial gas-detection alternative for factory monitoring.
- Agilent Technologies
Laboratory VOC analysis is an alternative to field olfaction systems.
ComparePre-market
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Ainos | $1.59 | +0.63% | $11.6M | — | — | 855.6 | −96.7% |
| Senseonics | $10.28 | +3.52% | $415.4M | — | — | 8.6 | +118.1% |
| Honeywell Technologies | $206.49 | +0.20% | $65.31B | 8.0 | 22.4 | 1.8 | −49.9% |
| Agilent Technologies | $152.51 | +0.76% | $42.76B | 29.8 | 23.0 | 5.8 | +8.1% |
| Median | 18.9 | 22.7 | 5.8 | +8.1% |